Thermo Fisher Scientific Inc (TMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 42,857,000 | 44,915,000 | 39,211,000 | 32,218,000 | 25,542,000 |
| Cost of Goods | 25,757,000 | 25,944,000 | 19,573,000 | 16,214,000 | 14,214,000 |
| Gross Profit | 17,100,000 | 18,971,000 | 19,638,000 | 16,004,000 | 11,328,000 |
| Operating Expenses | 10,241,000 | 10,578,000 | 9,610,000 | 8,210,000 | 6,734,000 |
| Operating Income | 6,859,000 | 8,393,000 | 10,028,000 | 7,794,000 | 4,594,000 |
| Interest Expense | 1,375,000 | 726,000 | 536,000 | 553,000 | 676,000 |
| Other Income | 755,000 | -4,000 | -655,000 | -14,000 | 154,000 |
| Pre-tax Income | 6,239,000 | 7,663,000 | 8,837,000 | 7,227,000 | 4,072,000 |
| Income Tax | 284,000 | 703,000 | 1,109,000 | 850,000 | 374,000 |
| Net Income Continuous | 5,955,000 | 6,960,000 | 7,728,000 | 6,377,000 | 3,698,000 |
| Minority Interests | -40,000 | 10,000 | 3,000 | 2,000 | 2,000 |
| Net Income | $5,995,000 | $6,950,000 | $7,725,000 | $6,375,000 | $3,696,000 |
| EPS Basic Total Ops | 15.52 | 17.75 | 19.62 | 16.09 | 9.24 |
| EPS Basic Continuous Ops | 15.43 | 17.76 | 19.61 | 16.10 | 9.25 |
| EPS Diluted Total Ops | 15.45 | 17.63 | 19.46 | 15.96 | 9.17 |
| EPS Diluted Continuous Ops | 15.35 | 17.67 | 19.47 | 15.98 | 9.18 |
| EPS Diluted Before Non-Recurring Items | 21.55 | 23.24 | 25.13 | 19.55 | 12.35 |
| EBITDA(a) | $10,265,000 | $11,774,000 | $12,620,000 | $10,119,000 | $6,871,000 |